Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01441713

Enrollment

178

Registered

2011-09-28

Start date

2011-09-30

Completion date

2012-06-30

Last updated

2012-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic Neoplasms

Keywords

Hormone treatment, castration, Orchiectomy, treatment frequency, treatment satisfaction, side effects

Brief summary

Patients with advanced prostate cancer usually receive some kind of pharmaceutical castration or undergo surgical castration. At the investigators department the pharmaceutical treatment is most often given with a 3 month interval. Over the last few years new drugs, which allow for lees frequent treatment, have been developed. The purpose of this study is to assess how the treatment affects patients and if our current patients would prefer to receive treatment at different intervals than they do at the present time. At the same time the investigators will assess how surgical treatment affects our patients. This will be assessed by patient questionnaires administered at our clinic.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* A diagnosis of advanced prostate cancer * Receiving hormone manipulation treatment (pharmaceutical castration) OR having undergone surgical castration (orchiectomy)

Exclusion criteria

* Inability to read/write Danish

Design outcomes

Primary

Measure	Time frame	Description
Preferred treatment/control frequency for patients with advanced prostate cancer	Up to 1 year	Preferred treatment frequency is assessed by patient answers to the question: If treatments were equally effective from a medical standpoint - How often would you then prefer to receive treatment

Secondary

Measure	Time frame	Description
Treatment satisfaction	Up to 1 year	Treatment satisfaction ranging from Very satisfied til Very unsatisfied assessed by patient answers to the questionnaire
Side effects to treatment	Up to 1 year	Side effects to treatment assessed by patient answers to the questionnaire
Treatment satisfaction, preferred frequency of clinical control, and side effects after surgical castration	Up to 1 year	As a secondary endpoint the investigators will look at answers to satisfaction, wishes for control visits and side effects in the group of patients who received surgical castration for their advanced prostate cancer.

Countries

Denmark

Outcome results